Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.22 -0.08 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.30 | 52 Week High | $18.00 | |||
| Open | $4.29 | 52 Week Low | $6.91 | |||
| Day High | $4.39 | P/E | N/A | |||
| Day Low | $4.20 | EPS | $-0.67 | |||
| Volume | 1,061,067 | |||||
